U.S. markets open in 55 minutes
  • S&P Futures

    3,625.50
    +24.00 (+0.67%)
     
  • Dow Futures

    29,023.00
    +222.00 (+0.77%)
     
  • Nasdaq Futures

    11,072.00
    +36.50 (+0.33%)
     
  • Russell 2000 Futures

    1,689.00
    +19.20 (+1.15%)
     
  • Crude Oil

    83.38
    +3.89 (+4.89%)
     
  • Gold

    1,677.20
    +5.20 (+0.31%)
     
  • Silver

    19.53
    +0.50 (+2.61%)
     
  • EUR/USD

    0.9767
    -0.0034 (-0.35%)
     
  • 10-Yr Bond

    3.7100
    -0.0940 (-2.47%)
     
  • Vix

    31.78
    -0.06 (-0.19%)
     
  • GBP/USD

    1.1212
    +0.0046 (+0.41%)
     
  • USD/JPY

    144.9040
    +0.1750 (+0.12%)
     
  • BTC-USD

    19,219.40
    +52.04 (+0.27%)
     
  • CMC Crypto 200

    437.02
    -6.41 (-1.44%)
     
  • FTSE 100

    6,861.19
    -32.62 (-0.47%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference

·2 min read

SEATTLE, February 09, 2022--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 11th Annual SVB Leerink Global Healthcare Conference. The conference will be held virtually from February 16-18, 2022.

Brad Gray, president and chief executive officer, is scheduled to present on Thursday, February 17, 2022, at 5:00pm ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,200 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString’s GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in approximately 90 peer-reviewed publications. The CosMx Spatial Molecular Imager, with commercial availability expected in the second half of 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.

For more information, please visit www.nanostring.com.

NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220209005028/en/

Contacts

Doug Farrell
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768